Инфекции у пациентов с опухолевыми заболеваниями кроветворной ткани: эффект внедрения стационарной защитной среды в отделении гематологии

И. О. Стома, И. А. Искров, И. Ю. Лендина, И. А. Карпов, А. Л. Усс УО «Белорусский государственный медицинский университет», УЗ «9-я городская клиническая больница», г. Минск

2018 №3 | Оригинальные научные публикации

Аннотация

Список литературы

Скачать полнотекстовую статью

До настоящего времени в международной научной литературе не было опубликовано данных о влиянии инновационных модулей защитной среды на спектр и характеристики инфекций у взрослых пациентов гематологического профиля. Целью данного пилотного клинического исследования было оценить изменения этиологического спектра и нозологических характеристик инфекций у пациентов группы высокого риска на фоне химиотерапии опухолевых заболеваний кроветворной ткани в контексте внедрения технологии многоступенчатой фильтрации, применяемой в аэрокосмической отрасли.

Ключевые слова:

инфекции в гематологии, сепсис, фебрильная нейтропения, инфекционный контроль, стационарная защитная среда

Infections in patients with tumor diseases of hematopoietic tissue: effect of introduction of stationary protective environment in hematology department

Currently there was a lack of understanding of effect of protective environment systems of spectrum and characteristics of infections in hematology. Aim of this pilot clinical study is to study the changes in infections in patients receiving chemotherapy in innovative protective environment systems based on space filtration technologies.

Keywords

infections in hematology, sepsis, febrile neutropenia, infection control, protected environment

1. Albiger, B. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015 / B. Albiger [et al.] // Eurosurveillance. – 2015. – Vol. 20, № 45.
2. Kazmierczak, K. M. Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-β-Lactamase- Producing Enterobacteriaceae and Pseudomonas aeruginosa / K. M. Kazmierczak [et al.] // Antimicrobial Agents and Chemotherapy. – 2016. – Vol. 60, № 2. – P. 1067–1078.
3. Falcone, M. Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase–producing K. pneumoniae / M. Falcone [et al.] // Clinical Microbiology and Infection. – 2016. – Vol. 22, № 5. – P. 444–450.
4. Tumbarello, M. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study / M. Tumbarello [et al.] // Journal of Antimicrobial Chemotherapy. – 2015. – Vol. 70, № 7. – P. 2133–2143.
5. Freifeld, A. G. Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America / A. G. Freifeld [et al.] // Clinical Infectious Diseases. – 2011. – Vol. 52, № 4. – P. E56–e93.
6. Tomblyn, M. Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective / M. Tomblyn [et al.] // Biology of Blood and Marrow Transplantation. – 2009. – Vol. 15, № 10. – P. 1143–1238.
7. Magiorakos, A.-P. Multidrug-resistant, extensively drugresistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance: International standard definitions for acquired resistance / A.-P. Magiorakos [et al.] // Clinical Microbiology and Infection. – 2012. – Vol. 18, № 3. – P. 268–281.
8. Buffie, C. G., Pamer E. G. Microbiota-mediated colonization resistance against intestinal pathogens / C. G. Buffie, E. G. Pamer // Nature Reviews Immunology. – 2013. – Vol. 13, № 11. – P. 790–801.
9. Taur, Y. Intestinal Domination and the Risk of Bacteremia in Patients Undergoing Allogeneic Hematopoietic Stem Cell Trans- plantation / Y. Taur [et al.] // Clinical Infectious Diseases. – 2012. – Vol. 55, № 7. – P. 905–914.
10. Libbrecht, C. Impact of a change in protected environment on the occurrence of severe bacterial and fungal infections in children undergoing hematopoietic stem cell transplantation / C. Libbrecht [et al.] // European Journal of Haematology. – 2016. – Vol. 97, № 1. – P. 70–77.
11. Taur, Y. et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation / Y. Taur [et al.] // Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. – 2012. – Vol. 55, № 7. – P. 905–914.
12. Becattini, S. Taur Y., Pamer E. G. Antibiotic-Induced Changes in the Intestinal Microbiota and Disease / S. Becattini, Y. Taur, E. G. Pamer // Trends in Molecular Medicine. – 2016. – Vol. 22, № 6. – P. 458–478.